
Aimee Donnellan
Columnist at Reuters
Columnist at Breakingviews
Columnist @reuters @Breakingviews (Pharma, property, retail and insurers) Former banking correspondent @st_business. Views mine.
Articles
-
1 week ago |
breakingviews.com | Aimee Donnellan |Jonathan Guilford
WestlawBuild the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. OnesourceThe most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. CheckpointThe industry leader for online information for tax, accounting and finance professionals.
-
1 week ago |
today.westlaw.com | Aimee Donnellan |Liam Proud |Streisand Neto
LONDON (Reuters Breakingviews) - De La Rue's rocky road on the public market may end on an unexpected high. On Tuesday, the UK banknote printer...
-
2 weeks ago |
breakingviews.com | Aimee Donnellan |Jonathan Guilford
WestlawBuild the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. OnesourceThe most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. CheckpointThe industry leader for online information for tax, accounting and finance professionals.
-
2 weeks ago |
cincodias.elpais.com | Aimee Donnellan
La industria de los medicamentos recetados tiene una inmunidad relativamente sólida a los aranceles. Donald Trump se abstuvo hace una semana de golpear a los productos farmacéuticos hace una semana. Continuó este martes diciendo que pronto anunciaría un arancel “significativo” a las importaciones farmacéuticas.
-
2 weeks ago |
breakingviews.com | Aimee Donnellan
WestlawBuild the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. OnesourceThe most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. CheckpointThe industry leader for online information for tax, accounting and finance professionals.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 1K
- DMs Open
- No

Hi, I’m writing a book and looking for people with lived experience of obesity. DM if you would like to be a case study

RT @Breakingviews: 🎙️ Novo Nordisk is ahead of the pharma pack with its Wegovy weight-loss drug. The Danish company’s CEO Lars Fruergaard…

RT @JacobGronholt: Don't miss live broadcast interview med Novo Nordisk CEO Lars Fruergaard Jørgensen today at 11 cet @Reuters @aimeedonnel…